Middletown, DE -- (SBWIRE) -- 09/24/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Peregrine Semiconductor Corp(NASDAQ:PSMI), Idera Pharmaceuticals Inc(NASDAQ:IDRA), PGT, Inc.(NASDAQ:PGTI), Vanda Pharmaceuticals Inc.(NASDAQ:VNDA)
Peregrine Semiconductor Corp(NASDAQ:PSMI) opened the session at $10.88, remained amid the day range of $9.44 - $10.88, and closed the session at $9.68. The stock showed a negative performance of -11.03% in previous trading session. The stock gained a volume of 1.21 million shares and the average volume of the stock remained 196,638.00 shares. Peregrine Semiconductor Corporation designs, develops, markets, and sells radio frequency integrated circuits (RFICs) based on UltraCMOS technology. Its products include radio frequency switches, digital attenuators, synthesizers, mixers/upconverters, prescalers, variable gain amplifiers, digitally tunable capacitors, DC-DC converters, and power amplifiers.
Will PSMI Get Buyers Even After The Recent Rally? Find Out Here
Idera Pharmaceuticals Inc(NASDAQ:IDRA) traded with volume of 1.13 million shares in the prior session and the average volume of the stock remained 611,956.00 shares. The 52 week range of the stock remained $0.19 - $2.34. The stock showed a negative movement of -7.57% and closed its session at $1.71. The market capitalization of the stock remained 79.90 million. Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, engages in the discovery and development of novel synthetic DNA- and RNA- based drug candidates. It is developing drug candidates designed to modulate immune responses mediated through Toll-like Receptors (TLRs); and evaluating gene silencing oligonucleotides (GSOs), which inhibit the production of disease-associated proteins by targeting RNA.
Why Should Investors Buy IDRA After the Recent Fall? Just Go Here and Find Out
PGT, Inc. (NASDAQ:PGTI) exchanged 1.13 million shares and the average volume remained 535,851.00 shares. The stock dropped -5.47% and closed the session at $10.37. The beta of the stock remained 2.04 and the EPS of the stock remained 0.39. The shares outstanding of the stock remained 45.76 million. PGT, Inc. engages in the manufacture and supply of residential impact-resistant windows and doors. The company offers impact-resistant products, including heavy-duty aluminum or vinyl frames with laminated glass to provide protection from hurricane-force winds and wind-borne debris.
Has PGTI Found The Bottom And Ready To Gain Momentum? Find Out Here
Vanda Pharmaceuticals Inc.(NASDAQ:VNDA) gained volume of 1.14 million shares, while the average volume remained 698,711.00 shares. The stock advanced +0.15% and finished the session Friday at $12.96. The EPS of the stock remained -0.67. The one month of the stock was +21.01% and three month trend remained positive +56.71%. Vanda Pharmaceuticals, Inc., a biopharmaceutical company, offers development and commercialization of products for the treatment of central nervous system disorders. The company provides Fanapt, a compound for the treatment of schizophrenia; and VLY-686, Vanda Pharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Washington, District of Columbia.
For How Long VNDA’s Gloss will Attract Investors? Find out via this report
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)